In a pre-clinical model of HNSCC cells, Zhang and colleagues knocked down Trop-2 resulting in increased membrane localization of NRG1 that binds to and increases the activation of ErbB3 [22]. Here, TACSTD2 is linked to head and neck squamous cell carcinoma.